Trial intelligence / Profile preview

NBF Gingival Gel for Post-surgical Complications in Third Molar Surgery

NCT03641482Completed

Sponsor
Complutense University of Madrid
Start
Sep 2016
Primary completion
Jul 2017
Modality
Nanoparticles, Transdermal Patches, Hydrogel Systems
01

Overview

Randomised, triple-blind trial in alveolar osteitis (AO) comparing NBF Gingival Gel with Placebo Gel (2 arms). Primary endpoint: Alveolar Osteitis Incidence at 72 hours. Started Sep 2016; status: completed.

02

Drugs

NBF Gingival Gel
03

Conditions

alveolar osteitis (AO)

Beyond the preview

Go deeper on NCT03641482.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03641482.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call